ClariVest Asset Management’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-16,296
Closed -$1.21M – 763
2023
Q1
$1.21M Sell
16,296
-14,988
-48% -$1.16M 0.05% 259
2022
Q4
$2.59M Sell
31,284
-132
-0.4% -$10.5K 0.12% 132
2022
Q3
$2.23M Sell
31,416
-9,744
-24% -$842K 0.11% 147
2022
Q2
$3.57M Sell
41,160
-10,800
-21% -$1.01M 0.16% 116
2022
Q1
$5.63M Sell
51,960
-800
-2% -$82.5K 0.22% 93
2021
Q4
$6.82M Sell
52,760
-5,200
-9% -$637K 0.21% 93
2021
Q3
$7.02M Sell
57,960
-6,436
-10% -$783K 0.23% 94
2021
Q2
$7.25M Hold
64,396
– – 0.24% 86
2021
Q1
$6.15M Buy
64,396
+2,036
+3% +$186K 0.22% 90
2020
Q4
$4.95M Hold
62,360
– – 0.17% 108
2020
Q3
$3.86M Sell
62,360
-2,040
-3% -$133K 0.13% 133
2020
Q2
$4.25M Buy
64,400
+4,800
+8% +$287K 0.12% 128
2020
Q1
$2.83M Buy
59,600
+4,000
+7% +$200K 0.08% 161
2019
Q4
$3.05M Sell
55,600
-1,600
-3% -$83.9K 0.07% 195
2019
Q3
$2.8M Buy
+57,200
New +$2.87M 0.06% 215
2018
Q2
– Sell
-65,900
Closed -$2.49M – 774
2018
Q1
$2.49M Buy
+65,900
New +$2.33M 0.04% 308
2014
Q2
– Sell
-110,468
Closed -$2.36M – 626
2014
Q1
$2.36M Buy
+110,468
New +$2.49M 0.1% 153

Other funds holding TECH

ClariVest Asset Management's TECH Position: Q2 2023 in Review

ClariVest Asset Management sold out of Bio-Techne (TECH) in Q2 2023, closing a stake of 16,296 shares — an estimated $1.21M sold.

ClariVest Asset Management first reported a position in TECH in Q1 2014 and held it in 17 quarters. The position peaked at $7.25M in Q2 2021. 529 funds tracked by Wall St. Rank hold TECH as of Q2 2023.

  • ClariVest Asset Management reported no remaining Bio-Techne position as of Q2 2023 after selling out during the quarter.
  • ClariVest Asset Management sold 16,296 Bio-Techne shares in Q2 2023, an estimated $1.21M.
  • ClariVest Asset Management first reported a position in Bio-Techne in Q1 2014 and held it in 17 quarters.
  • ClariVest Asset Management's Bio-Techne position peaked at $7.25M in Q2 2021.
  • 529 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2023.

Based on ClariVest Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.